|
"tseng js"的相關文件
顯示項目 1-10 / 19 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2023-11-01 |
Low-dose computed tomography screening in relatives with a family history of lung cancer
|
Wang, CL;Hsu, KH;Chang, YH;Ho, CC;Chiang, CJ;Chen, KC;Cheung, YC;Huang, PC;Chen, YR;Chen, CY;Hsu, CP;Hsia, JY;Chen, HY;Yang, SY;Li, YJ;Yang, TY;Tseng, JS;Chuang, CY;Hsiung, CA;Chen, YM;Huang, MS;Yu, CJ;Chen, KY;Su, WC;Chen, J;Yu, SL;Chen, CJ;Yang, PC;Tsai, YH;Chang, GC |
| 國家衛生研究院 |
2023-07-04 |
Low-dose CT screening in relatives with a family history of lung cancer
|
Wang, CL;Hsu, KH;Chang, YH;Ho, CC;Chiang, CJ;Chen, KC;Cheung, YC;Huang, PC;Chen, YR;Chen, CY;Hsu, CP;Hsia, JY;Chen, HY;Yang, SY;Li, YJ;Yang, TY;Tseng, JS;Chuang, CY;Hsiung, CA;Chen, YM;Huang, MS;Yu, CJ;Chen, KY;Su, WC;Chen, JJW;Yu, SL;Chen, CJ;Yang, PC;Tsai, YH;Chang, GC |
| 國家衛生研究院 |
2023-02-28 |
Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
|
Lee, PH;Chiang, CJ;Tseng, JS;Zheng, ZR;Chen, KC;Chu, CH;Huang, YH;Hsu, KH;Lee, WC;Yang, TY;Liu, TW;Hsia, JY;Chang, GC |
| 國家衛生研究院 |
2022-03-01 |
Association of smoking with patient characteristics and outcomes in small cell lung carcinoma, 2011-2018
|
Tseng, JS;Chiang, CJ;Chen, KC;Zheng, ZR;Yang, TY;Lee, WC;Hsu, KH;Huang, YH;Liu, TW;Hsia, JY;Chang, GC |
| 國家衛生研究院 |
2021-04-30 |
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors
|
Lee, PH;Yang, TY;Chen, KC;Huang, YH;Tseng, JS;Hsu, KH;Wu, YC;Liu, KJ;Chang, GC |
| 中山醫學大學 |
2021 |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, YH; Hung, JY; Ko, HW; Su, PL; Lai, CL; Chang, HC; Hsia, TC; Lin, SH; Wu, KL; Yang, CT; Su, WC; Chu, YC; Wang, CC; Liao, WY; Lin, YT; Lin, CH; Lin, MC; Hsu, KH; Tseng, JS; Yang, TY; Chen, KC; Lee, MH; Yu, SL; Ho, CC; Chang, GC |
| 中山醫學大學 |
2021 |
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naive Advanced EGFR-Mutant Lung Adenocarcinoma Patients
|
Hsu, KH; Huang, JW; Tseng, JS; Chen, KW; Weng, YC; Yu, SL; Yang, TY; Huang, YH; Chen, JJ; Chen, KC; Chang, GC |
| 中山醫學大學 |
2021 |
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment
|
Tseng, JS; Hsu, KH; Zheng, ZR; Yang, TY; Chen, KC; Huang, YH; Su, KY; Yu, SL; Chang, GC |
| 中山醫學大學 |
2021 |
Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma <= 2 cm in size: A retrospective cohort study
|
Wu, JJ; Wu, CY; Wu, CY; Wang, CL; Yang, TY; Tseng, JS; Hsu, KH; Huang, YH; Hsu, CP; Chuang, CY; Lin, CH; Tseng, CH; Chen, KC; Chang, GC |
| 中山醫學大學 |
2021 |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Response
|
Su, SF; Liu, CH; Cheng, CL; Ho, CC; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chen, HW; Chang, GC; Yu, SL; Li, KC |
顯示項目 1-10 / 19 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
